CZ196693A3 - Thiazolidinedione derivatives, and process for preparing thereof - Google Patents

Thiazolidinedione derivatives, and process for preparing thereof Download PDF

Info

Publication number
CZ196693A3
CZ196693A3 CS931966A CS196693A CZ196693A3 CZ 196693 A3 CZ196693 A3 CZ 196693A3 CS 931966 A CS931966 A CS 931966A CS 196693 A CS196693 A CS 196693A CZ 196693 A3 CZ196693 A3 CZ 196693A3
Authority
CZ
Czechia
Prior art keywords
thiazolidinedione
pyridyl
compound
derivative according
benzyl
Prior art date
Application number
CS931966A
Other languages
Czech (cs)
English (en)
Inventor
Takashi Sohda
Hitoshi Ikeda
John C Greenfield
Jerry R Colca
Edgar N Petzold
Original Assignee
Upjohn Co
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13672917&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CZ196693(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co, Takeda Chemical Industries Ltd filed Critical Upjohn Co
Publication of CZ196693A3 publication Critical patent/CZ196693A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Lubricants (AREA)
  • Graft Or Block Polymers (AREA)
CS931966A 1991-04-11 1992-04-06 Thiazolidinedione derivatives, and process for preparing thereof CZ196693A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7883691 1991-04-11
PCT/US1992/002566 WO1992018501A1 (en) 1991-04-11 1992-04-06 Thiazolidinedione derivatives, production and use thereof

Publications (1)

Publication Number Publication Date
CZ196693A3 true CZ196693A3 (en) 1994-05-18

Family

ID=13672917

Family Applications (1)

Application Number Title Priority Date Filing Date
CS931966A CZ196693A3 (en) 1991-04-11 1992-04-06 Thiazolidinedione derivatives, and process for preparing thereof

Country Status (19)

Country Link
EP (1) EP0579733B1 (enExample)
JP (1) JP3176694B2 (enExample)
KR (1) KR100249988B1 (enExample)
AT (1) ATE202352T1 (enExample)
AU (1) AU1743292A (enExample)
CA (1) CA2106967C (enExample)
CZ (1) CZ196693A3 (enExample)
DE (1) DE69231886T2 (enExample)
DK (1) DK0579733T3 (enExample)
ES (1) ES2161692T3 (enExample)
FI (1) FI934426L (enExample)
GR (1) GR3036623T3 (enExample)
HU (1) HUT68370A (enExample)
MX (1) MX9201637A (enExample)
NO (1) NO933615D0 (enExample)
PT (1) PT100366A (enExample)
SK (1) SK109993A3 (enExample)
TW (1) TW209864B (enExample)
WO (1) WO1992018501A1 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993022445A1 (en) * 1992-05-05 1993-11-11 The Upjohn Company A process for producing pioglitazone metabolite
TW268952B (enExample) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
CZ289317B6 (cs) * 1994-04-11 2002-01-16 Sankyo Company Limited Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5952509A (en) * 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds
DE69837089T2 (de) 1997-06-18 2007-06-21 Smithkline Beecham P.L.C., Brentford Behandlung der diabetes mit thiazolidindion und sulfonylharnstoff
CZ20011629A3 (cs) 1998-11-12 2001-12-12 Smithkline Beecham Plc Farmaceutický prostředek pro upravené uvolňování senzitizéru inzulínu a jiných antidiabetických přípravků
AR023700A1 (es) 1998-11-12 2002-09-04 Smithkline Beecham Plc Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
GB0014969D0 (en) 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
DE20119200U1 (de) 2001-11-27 2003-04-10 Joh. Winklhofer & Söhne GmbH und Co KG, 81369 München Kettenspanner mit mechanischer Verriegelung
US8268352B2 (en) 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
KR100646128B1 (ko) 2005-04-21 2006-11-14 전라옥 ＰＰＡＲγ에 선택적으로 작용하는 테트라하이드로퀴놀린계열 티아졸리딘디온 유도체 및 그 합성방법
AU2013200104B2 (en) * 2006-03-16 2014-05-15 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
MX2008011870A (es) * 2006-03-16 2009-02-10 Metabolic Solutions Dev Compan Terapias de combinacion de analogos de tiazolidindiona y agonistas glucocorticoides.
CA2646207C (en) * 2006-03-16 2016-01-19 Metabolic Solutions Development Company Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
ES2388555T3 (es) * 2006-03-16 2012-10-16 Metabolic Solutions Development Company Llc Análogos de tiazolidindiona
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2008038359A1 (en) * 2006-09-28 2008-04-03 Daido Kogyo Co., Ltd. Chain tensioner
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
NZ597381A (en) 2007-09-14 2013-03-28 Metabolic Solutions Dev Co Llc Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases
US8722710B2 (en) 2007-09-26 2014-05-13 Deuterx, Llc Deuterium-enriched pioglitazone
HUE038042T2 (hu) * 2009-12-15 2018-09-28 Cirius Therapeutics Inc PPAR helyettesítõ tiazolidindion sók metabolikus betegségek kezelésére
EP2560956B1 (en) * 2010-04-19 2016-10-26 Octeta Therapeutics, LLC Novel synthesis for thiazolidinedione compounds
AU2011242955A1 (en) * 2010-04-19 2012-11-01 Metabolic Solutions Development Company, Llc Novel synthesis for thiazolidinedione compounds
HUE031424T2 (en) 2010-08-10 2017-07-28 Octeta Therapeutics Llc New synthesis of thiazolidinedione compounds
PL2603507T3 (pl) * 2010-08-10 2016-12-30 Synteza związków tiazolidynodionu
US20120094959A1 (en) 2010-10-19 2012-04-19 Bonnie Blazer-Yost Treatment of cystic diseases
JP6800013B2 (ja) * 2013-03-14 2020-12-16 ポクセル・ソシエテ・アノニムＰｏｘｅｌ ＳＡ 重水素化２，４−チアゾリジンジオン及び治療方法
US10188639B2 (en) 2014-01-15 2019-01-29 Deuterx, Llc Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
SG11201608218QA (en) * 2014-04-02 2016-10-28 Minoryx Therapeutics S L 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders
WO2016071727A1 (en) 2014-11-04 2016-05-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the prevention and the treatment of rapidly progressive glomerulonephritis
AU2017370003B2 (en) 2016-12-01 2023-04-13 Minoryx Therapeutics S.L. 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine- 2,4-dione for treating nonalcoholic fatty liver disease
ES2926580T3 (es) * 2016-12-23 2022-10-27 Minoryx Therapeutics S L Proceso para preparar 5-[[4-[2-[5-(1-hidroxietil)-2-piridinil]etoxi]fenil]metil]-2,4-tiazolidindiona y sales de la misma
US11767317B1 (en) 2020-06-30 2023-09-26 Poxel Sa Methods of synthesizing enantiopure deuterium-enriched pioglitazone
US11319313B2 (en) 2020-06-30 2022-05-03 Poxel Sa Crystalline forms of deuterium-enriched pioglitazone
WO2024231881A2 (en) * 2023-05-09 2024-11-14 Minoryx Therapeutics S.L. Polymorphic forms and formulations of leriglitazone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales

Also Published As

Publication number Publication date
GR3036623T3 (en) 2001-12-31
DE69231886T2 (de) 2002-03-28
ES2161692T3 (es) 2001-12-16
FI934426A7 (fi) 1993-10-08
CA2106967A1 (en) 1992-10-12
EP0579733B1 (en) 2001-06-20
EP0579733A1 (en) 1994-01-26
TW209864B (enExample) 1993-07-21
AU1743292A (en) 1992-11-17
CA2106967C (en) 2003-12-09
KR100249988B1 (ko) 2000-04-01
SK109993A3 (en) 1994-12-07
JPH0586057A (ja) 1993-04-06
DK0579733T3 (da) 2001-10-15
FI934426A0 (fi) 1993-10-08
MX9201637A (es) 1993-08-01
PT100366A (pt) 1993-06-30
NO933615L (no) 1993-10-08
HUT68370A (en) 1995-06-28
WO1992018501A1 (en) 1992-10-29
JP3176694B2 (ja) 2001-06-18
FI934426L (fi) 1993-10-08
DE69231886D1 (de) 2001-07-26
ATE202352T1 (de) 2001-07-15
NO933615D0 (no) 1993-10-08

Similar Documents

Publication Publication Date Title
EP0579733B1 (en) Thiazolidinedione derivatives, production and use thereof
US5441971A (en) Thiazolidinedione derivatives, production and use thereof
US6100403A (en) Production of benzaldehyde compounds
JPS61286376A (ja) チアゾリジン誘導体およびそれを含んでなる医薬組成物
HU195210B (en) Process for producing pyridine derivatives and pharmaceutical preparations comprising these compounds as active substance
US5183823A (en) Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
KR100198183B1 (ko) 퀴논기를 함유하는 티아졸리딘 화합물, 이의 제조방법 및 치료용도
EP0299620A1 (en) Thiazolidinedione derivatives
NO176317B (no) Fremgangsmåte for frestilling av terapeutisk aktive oksoftalazinyl-eddiksyre-derivater med benzotiazol-sidekjede
JP2707936B2 (ja) β−オキソ−β−ベンゼンプロパンチオアミド誘導体
CZ20001633A3 (cs) Způsob přípravy thiazolidindionových derivátů
FR2510113A1 (enExample)
US5130315A (en) 1-piperazinyl-2-butenes and -2-butynes
US4735955A (en) 2-substituted cycloheptoimidazole derivatives and anti-ulcerative agents containing the same
US4748280A (en) Certain chlorination process for preparing 2-chloro-1,1,1-(C1 -C6)
GB2053897A (en) Piperazine derivatives
JPS60208980A (ja) チアゾリジンジオン誘導体、その製造法およびそれを含んでなる糖尿病または高脂血症治療剤
JP2826646B2 (ja) ３−置換−５−ハロゲノピリジン誘導体
CA1298294C (fr) Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
CZ233692A3 (en) Quinolin-2-yl-methoxybenzyl hydroxyureas
JPH11116576A (ja) ２−クロロ−ベンズイミダゾール誘導体の製造方法
JPH07215952A (ja) カテコール誘導体
US5414006A (en) Arylalkoxythiocoumarins, the preparation thereof and therapeutic compositions containing these
CZ357190A3 (en) Dihydropyrimidothiazine derivatives, process of their preparation and pharmaceutical compositions containing thereof
JPH10139768A (ja) ナフタレン誘導体の製造方法